Alkermes plc. Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount
Alkermes plc. (ALKS) reported Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount of $248.00 thousand for the 12-month period ending 2020-12-31, per its 10-K filed 2022-02-16.
Discontinued › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate · last filed 2022-02-16
- Alkermes plc. effective income tax rate reconciliation, change in enacted tax rate, amount for fiscal 2020 was $248.00K.
- Alkermes plc. effective income tax rate reconciliation, change in enacted tax rate, amount for fiscal 2019 was -$8.11M.
| Period end | Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount 9 month | Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount 12 month |
|---|---|---|
| 2020-12-31 | $248.00K 10-K · filed 2022-02-16 | |
| 2019-12-31 | -$8.11M 10-K · filed 2022-02-16 | |
| 2013-12-31 | $686.00K 10-K · filed 2016-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |